|
Match
|
Document |
Document Title |
|
|
7629356 |
Substituted pyrrolo[3,4-b]pyridinamines and pharmaceutical compositions
This invention relates to substituted pyrrolo[3,4-b]pyridinamines having the structural formula IA below:
and to their pharmaceutically acceptable salt, compositions and methods of use. These...
|
|
|
7625905 |
Octahydro-pyrrolo[3,4-c]pyrrole CCR5 receptor antagonists
Chemokine receptor antagonists, in particular, 3,7-diazabicyclo[3.3.0]octane compounds according to formula (I) wherein R 1 -R 3 and Ar are as defined herein are antagonists of chemokine CCR5...
|
|
|
7615567 |
Compounds and methods for promoting smoking cessation
Compounds and methods for promoting smoking cessation. The compounds may be used to treat a variety of other conditions and disease states.
|
|
|
7598236 |
Diazabicyclic central nervous system active agents
Compounds of formula I
pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
|
|
|
7579362 |
Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
The present invention relates to 1-aza-bicycloalkyl derivatives of formula I,
wherein X is CH 2 or a single bond; Y is a group of formula
and wherein R has the meanings as defined in the...
|
|
|
7547722 |
Chemical compounds
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I):
wherein: R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the specification, which are useful as...
|
|
|
7538226 |
(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
The present invention discloses (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]
heptane, salts thereof, and its use to treat pain and other disorders associated with the nicotinic...
|
|
|
7511056 |
TGF-β inhibitors
The present invention is directed to inhibitors of TGF-β of Formula I:
|
|
|
7501076 |
Fluorescent diketopyrrolopyrroles
The present invention relates to fluorescent diketopyrrolopyrrole of the formula (I), a process for their preparation and their use for the preparation of inks, colorants, pigmented plastics for...
|
|
|
7498444 |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
The present invention relates to the salt (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]
heptane benzenesulfonate and to methods of preparing the salt.
|
|
|
7456289 |
Anti-tumor compounds
Compounds of the following formula:
wherein A, D, Q, T, U, V, W, X, Y, Z, R 1 , and are as defined herein. This invention also relates to a method of inhibiting tubulin polymerization, or...
|
|
|
7449447 |
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said...
|
|
|
7446122 |
Substituted indole derivatives
Provided herein are indole derivatives, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
|
|
|
7399765 |
Substituted diazabicycloalkane derivatives
Compounds of formula (I)
Z-Ar 1 —Ar 2 (I)
wherein Z is a diazabicyclic...
|
|
|
7393867 |
Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I
The present invention discloses and claims compounds of formula (I) and formula (II),
as inhibitors of human casein kinase Iε and methods for using said compounds for treating central nervous...
|
|
|
7390798 |
Carboxamide spirolactam CGRP receptor antagonists
The present invention is directed to compounds of Formula I: I (where variables A 1 , A 2 , B, J, K, m, n, R 4 , R 5a , R 5b and R 5c are as defined herein) useful as antagonists of CGRP...
|
|
|
7384946 |
M3 muscarinic acetylcholine receptor antagonists
Novel dimeric benzoazabicyclohepatane compounds, pharmaceutical compositions, processes for their preparation and use thereof in treating M 3 muscarinic acetylcholine receptor mediated diseases...
|
|
|
7351733 |
Tetrahydrocarbazole derivatives and their pharmaceutical use
The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.
|
|
|
7326793 |
Process for the preparation of diketopyrrolopyrroles
The present invention relates to a process for the preparation of diketopyrrolopyrroles of the formula (I), wherein A1, A2, A3 and A4 are as defined in the description of the present invention, to...
|
|
|
7319106 |
Diazabicyclic central nervous system active agents
Compounds of formula I
pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
|
|
|
7268158 |
6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I):
wherein: R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the specification, which are useful as...
|
|
|
7265115 |
Diazabicyclic CNS active agents
Compounds of formula I:
or pharmaceutically acceptable salts thereof, are useful for controlling synaptic transmission in mammals.
|
|
|
7253168 |
Substituted 1-benzyl-4-substituted piperazine analogues
Compounds of Formula I are provided, in which variables are as described herein:
Such compounds may be used to modulate MCH binding to MCH receptors in vivo or in vitro, and are particularly...
|
|
|
7235567 |
Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
A crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist compound, which exhibits a powder x-ray diffraction profile substantially the same as that shown in FIG. 1 , or which...
|
|
|
7173047 |
Benzo (f) insoindol derivatives and their use as ep4 receptor ligands
Compounds of formula (I)
and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a...
|
|
|
7153848 |
Inhibitors of HCV replication
Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV. Different forms and compositions...
|
|
|
7135484 |
Azabicyclic compounds are central nervous system active agents
Compounds of formula (I)
are novel CNS active agents that are useful for treating pain and for treating other disorders associated with the cholinergic system.
|
|
|
7132442 |
6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin releasing hormone (GnRH)
The invention relates to a group of novel thieno-pyrrole compounds of Formula (I): wherein: R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the specification, which are useful as gonadotrophin...
|
|
|
7122570 |
Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
This invention provides new tetrahydrocarbazole derivatives that act as ligands for G-protein-coupled receptors (GPCR), especially as antagonists of the gonadotropin-releasing hormone (GnRH). A...
|
|
|
7094800 |
Cyanopyrrolidides, process for their preparation and their use as medicaments
The invention relates to compounds of the formula I
in which the radicals have the meanings stated in the text, their stereoisomeric forms, and their physiologically tolerated salts,...
|
|
|
7081458 |
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
Melanin concentrating hormone receptor ligands (especially 1-benzyl-4-aryl-piperazines, 1-benzyl-4-aryl-piperidines and related compounds), capable of modulating MCH receptor activity, are...
|
|
|
7071207 |
Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
This invention relates to 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives which have been found to suppress appetite and induce weight loss. The invention also provides methods for synthesis...
|
|
|
7053108 |
Indoline compounds
A compound of formula (I):
wherein:
R 1 and R 2 together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or...
|
|
|
7041235 |
Fluorescent diketopyrrolopyrrole analogues
The present invention relates to fluorescent diketopyrrolopyrrole analogues of the general formula (I), wherein A 1 and A 2 are C 1 –C 18 alkyl, C 2 –C 18 alkenyl, C 2 –C 18 alkynyl, C 5...
|
|
|
7041684 |
Selective β3 adrenergic agonists
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective β 3 receptor...
|
|
|
7022706 |
Pharmaceutical compositions and methods for use
Pharmaceutical compositions incorporate compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and...
|
|
|
6949539 |
Admantane derivatives
The invention provides compounds of general formula (I) in which m, A, R 1 and Ar have the meanings defined in the specification; a process for their preparation; pharmaceutical compositions...
|
|
|
6939867 |
β3 agonists and uses thereof
Sulfamide compounds having formula (I) are described as well as their use in the treatment of diseases dependent on the signaling pathways associated with β-adrenergic receptors, such as obesity,...
|
|
|
6924297 |
Naphathalene derivatives which bind to the EP4 receptor
Compounds of formula (I)
and pharmaceutically acceptable derivatives thereof bind with high affinity to the EP4 receptor and are of use in the treatment or prevention of conditions such as a...
|
|
|
6852716 |
Substituted-aryl compounds for treatment of disease
The invention provides compounds of Formula I:
These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of...
|
|
|
6821964 |
Modulators of chemokine receptor activity
Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses...
|
|
|
6759421 |
Indoline compounds, a process for their preparation and pharmaceutical compositions containing them
A compound of formula (I): wherein: R 1 and R 2 together form a benzo ring optionally substituted by halogen or by alkyl, alkoxy, cyano, nitro, hydroxy, amino, alkylamino, dialkylamino or...
|
|
|
6723138 |
Preparation of diketopyrrolopyrrole pigments
A process for preparing diketopyrrolopyrrole pigments comprises conducting the elementary steps of pigment synthesis (reaction and hydrolysis) in a miniaturized continuous reactor.
|
|
|
6716856 |
4,5,6,7-tetrahydroindazole derivatives as antitumor agents
Compounds which are 4,5,6,7-tetrahydroindazole derivative formula (1), wherein the dotted line (x) represents a single or double bond; n is 0 or 1; R 1 , R 2 and R 3 have the meanings reported in...
|
|
|
6649613 |
Diacylhydrazine derivatives
Diacylhydrazine derivatives of general formula (I) wherein X, Y, Z, R 1 , 2 and R 3 are as defined herein, and their physiologically acceptable salts or solvates thereof, are integrin...
|
|
|
6586452 |
C1 to C4 side chain modified nodulisporic acid analogs
The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.
|
|
|
6579878 |
Pharmaceutical compositions and methods for use
Pharmaceutical compositions incorporate compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and...
|
|
|
6570019 |
Cationic pyrrolo-pyrrol-derivatives, method for producing them and colorants for keratin fibers, containing these compounds
The object of the present invention are diketopyrrolopyrroles of the general formula (I) wherein, independently of one another, Q 1 and Q 2 represent an optionally substituted, aromatic,...
|
|
|
6562816 |
Substituted-heteroaryl-7-aza&lsqb 2.2.1&rsqb bicycloheptanes for the treatment of disease
The invention provides compounds of Formula I: compounds of the Formula I: wherein R 1 , R 2 , R 4 , R 6 , X, and W are defined herein. These compounds may be in the form of pharmaceutical salts...
|
|
|
6538010 |
Compounds and methods for promoting smoking cessation
Compounds and methods for promoting smoking cessation. The compounds may be used to treat a variety of other conditions and disease states.
|